Iqbal O - Search Results

1

Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels.

Jeske W, Kouta A, Farooqui A, Siddiqui F, Rangnekar V, Niverthi M, Laddu R, Hoppensteadt D, Iqbal O, Walenga J, Fareed J. Jeske W, et al. Among authors: iqbal o. Front Med (Lausanne). 2019 Jan 9;5:360. doi: 10.3389/fmed.2018.00360. eCollection 2018. Front Med (Lausanne). 2019. PMID: 30687709 Free PMC article.

2

The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model.

Bacher P, Welzel D, Iqbal O, Hoppensteadt D, Callas D, Walenga JM, Fareed J. Bacher P, et al. Among authors: iqbal o. Thromb Res. 1992 May 1;66(2-3):151-8. doi: 10.1016/0049-3848(92)90185-d. Thromb Res. 1992. PMID: 1329252

3

Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates.

Fareed J, Coker S, Iqbal O, Hoppensteadt D, Walenga JM. Fareed J, et al. Among authors: iqbal o. Semin Thromb Hemost. 1991;17 Suppl 2:147-52. Semin Thromb Hemost. 1991. PMID: 1948085 No abstract available.

4

Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.

Jeske W, Lormeau JC, Callas D, Iqbal O, Hoppensteadt D, Fareed J. Jeske W, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):193-200. doi: 10.1055/s-2007-1000395. Semin Thromb Hemost. 1995. PMID: 7660142

5

Pharmacologic profile of a low-molecular-weight heparin depolymerized by gamma-irradiation.

Jeske W, Iqbal O, Gonnela S, Boveri G, Torri G, De Ambrosi L, Fareed J. Jeske W, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):201-11. doi: 10.1055/s-2007-1000396. Semin Thromb Hemost. 1995. PMID: 7660143

6

Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparin.

Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A. Fareed J, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):212-27. doi: 10.1055/s-2007-1000397. Semin Thromb Hemost. 1995. PMID: 7660144

7

Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week period.

Lojewski B, Bacher P, Iqbal O, Walenga JM, Hoppensteadt D, Leya F, Fareed J. Lojewski B, et al. Among authors: iqbal o. Semin Thromb Hemost. 1995;21(2):228-39. doi: 10.1055/s-2007-1000398. Semin Thromb Hemost. 1995. PMID: 7660145

8

Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.

Callas D, Bacher P, Iqbal O, Hoppensteadt D, Fareed J. Callas D, et al. Among authors: iqbal o. Thromb Res. 1994 May 1;74(3):193-205. doi: 10.1016/0049-3848(94)90108-2. Thromb Res. 1994. PMID: 8042188

9

The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal models.

Bacher P, Walenga JM, Iqbal O, Bajusz S, Breddin K, Fareed J. Bacher P, et al. Among authors: iqbal o. Thromb Res. 1993 Aug 15;71(4):251-63. doi: 10.1016/0049-3848(93)90195-t. Thromb Res. 1993. PMID: 8236155

10

Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide.

Callas DD, Hoppensteadt DA, Jeske W, Iqbal O, Bacher P, Ahsan A, Fareed J. Callas DD, et al. Among authors: iqbal o. Semin Thromb Hemost. 1993;19 Suppl 1:49-57. Semin Thromb Hemost. 1993. PMID: 8362269 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters